NextCure to present SIM0505 cancer drug data at ASCO 2026

April 21, 2026 10:15 AM

NextCure Inc. (NASDAQ: NXTC) and Simcere Zaiming Pharmaceutical Co. will present Phase 1 data for SIM0505 at the American Society ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found